Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension

INTRODUCTION: Currently available endothelin receptor antagonists for treating pulmonary arterial hypertension block either the endothelin (ET) receptor A or both A and B receptors. Transition from one endothelin receptor antagonist to another may theoretically alter side-effects or efficacy. We rep...

Descripción completa

Detalles Bibliográficos
Autor principal: Safdar, Zeenat
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064451/
https://www.ncbi.nlm.nih.gov/pubmed/21468170
http://dx.doi.org/10.2147/VHRM.S15026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064451/
https://www.ncbi.nlm.nih.gov/pubmed/21468170
http://dx.doi.org/10.2147/VHRM.S15026

Ejemplares similares